Comparative Analysis of Ferumoxytol and Gadoteridol Enhancement Using T1- and T2-Weighted MRI in Neuroimaging

Abstract

Ferumoxytol may be a useful MRI contrast agent in patients who are unable to receive gadolinium-based contrast agents. Greater experience with a wider variety of disorders is necessary to understand differences in enhancement with ferumoxytol compared with gadolinium-based contrast agents, given their different mechanisms of action.